EU Authorised Representative · EUDAMED Registration · Technical Documentation · Class B Deadline May 2027
Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices (IVDR) governs all diagnostic test kits, blood glucose meters, pregnancy tests, laboratory analysers, and companion diagnostics placed on the EU market. IVDR replaces the old IVDD and introduces significantly stricter requirements — including Notified Body involvement for most devices that were previously self-certified.
| Class | Risk & Requirements |
|---|---|
| Class A | Lowest risk. General laboratory equipment, sample transport. Self-certification. No NB required. |
| Class B | Medium risk. Blood glucose meters, pregnancy tests, self-tests. Notified Body required. Deadline: May 2027. |
| Class C | High risk. Blood group testing, HLA typing, HIV screening. Notified Body required. Deadline: May 2026 — already passed. |
| Class D | Highest risk. Blood transfusion screening, HIV confirmatory. Notified Body required. Deadline: May 2025 — already passed. |
The Class B compliance deadline is May 2027. That is less than nine months away. Companies that have not started their IVDR compliance programme are already behind. Notified Body pre-submission slots are months out. If you have Class B IVDs on the EU market, the time to act is now — not in 2027.
If your manufacturing site is outside the EU or EEA, you must appoint an EU Authorised Representative before placing any IVD on the EU market under IVDR. The EU AR name and address must appear on your device label. NordMDR AB acts as EU AR for IVD manufacturers across Asia, the Americas, and beyond.
NordMDR AB provides EU Authorised Representative and EUDAMED registration services for IVD manufacturers — combine with our EU MDR compliance support if you also place medical devices on the EU market.
The Class B deadline is May 2027. Book a free 30-minute call with NordMDR to discuss your IVDR compliance pathway.
Contact NordMDR Today →